Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...

The AI revolution in biology is built on a foundation of openness —researchers sharing data, code, and ideas freely so that others can build on them.

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design proteins needed for new treatments. In their study published in the journal ...

A multinational research team led by researchers at Institute of Science Tokyo, RIKEN, and the University of Toronto has ...

A recently identified bacterial protein, named BeeR, is contributing to the design of novel anticancer drug delivery systems. Researchers from King’s College London (UK) and the University of ...

Illustration showing how integrating protein three-dimensional structures with artificial intelligence algorithms can predict synergistic or antagonistic effects of drug combinations, guiding safer ...

Leveraging AI and quantum calculations, scientists developed a new tool that yielded higher-quality structural information and solved notoriously elusive proteins.

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered – which could help drug delivery in cancer treatment. In a paper published in PNAS, ...

CAMBRIDGE, England & BOSTON & VILLIGEN, Switzerland--(BUSINESS WIRE)--Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based ...